Pear Tree Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Pear Tree Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$31.1M	Sell	619,319 -38,300	-6%	-$2.04M	13.07%	4
2016 Q1	$35.2M	Hold	657,619	–	–	14.41%	3
2015 Q4	$43.2M	Hold	657,619	–	–	17.92%	1
2015 Q3	$37.1M	Buy	+657,619	New	+$42.6M	25.45%	2
2015 Q2	–	Sell	-657,619	Closed	-$41M	–	48
2015 Q1	$41M	Sell	657,619 -40,000	-6%	-$2.33M	33.15%	2
2014 Q4	$40.1M	Hold	697,619	–	–	31.34%	1
2014 Q3	$37.5M	Hold	697,619	–	–	30.33%	1
2014 Q2	$36.6M	Hold	697,619	–	–	28.5%	1
2014 Q1	$36.9M	Buy	697,619 +11,900	+2%	+$550K	30.12%	1
2013 Q4	$27.5M	Buy	685,719 +36,300	+6%	+$1.43M	34.17%	2
2013 Q3	$24.5M	Buy	649,419 +104,500	+19%	+$4.08M	26.45%	2
2013 Q2	$21.4M	Buy	+544,919	New	+$21.2M	28.54%	1

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pear Tree Advisors's TEVA Position: Q2 2016 in Review

Pear Tree Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 5.8% in Q2 2016, selling an estimated $2.04M and leaving 619,319 shares worth $31.1M. The position accounts for 13.07% of the portfolio, ranked #4.

Pear Tree Advisors first reported a position in TEVA in Q2 2013 and has held it in 12 quarters since. The position peaked at $43.2M in Q4 2015. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Pear Tree Advisors held 619,319 shares of Teva Pharmaceuticals worth $31.1M as of Q2 2016.
Pear Tree Advisors sold 38,300 Teva Pharmaceuticals shares in Q2 2016, an estimated $2.04M.
Teva Pharmaceuticals made up 13.07% of Pear Tree Advisors's portfolio in Q2 2016, its #4 holding.
Pear Tree Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Pear Tree Advisors's Teva Pharmaceuticals position peaked at $43.2M in Q4 2015.
812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Pear Tree Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.